1. Home
  2. BMRN vs ALAB Comparison

BMRN vs ALAB Comparison

Compare BMRN & ALAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRN
  • ALAB
  • Stock Information
  • Founded
  • BMRN 1996
  • ALAB 2017
  • Country
  • BMRN United States
  • ALAB United States
  • Employees
  • BMRN N/A
  • ALAB N/A
  • Industry
  • BMRN Biotechnology: Pharmaceutical Preparations
  • ALAB
  • Sector
  • BMRN Health Care
  • ALAB
  • Exchange
  • BMRN Nasdaq
  • ALAB NYSE
  • Market Cap
  • BMRN 12.1B
  • ALAB 10.6B
  • IPO Year
  • BMRN 1999
  • ALAB 2024
  • Fundamental
  • Price
  • BMRN $59.82
  • ALAB $71.64
  • Analyst Decision
  • BMRN Buy
  • ALAB Strong Buy
  • Analyst Count
  • BMRN 22
  • ALAB 13
  • Target Price
  • BMRN $93.43
  • ALAB $98.15
  • AVG Volume (30 Days)
  • BMRN 1.6M
  • ALAB 3.4M
  • Earning Date
  • BMRN 05-01-2025
  • ALAB 05-06-2025
  • Dividend Yield
  • BMRN N/A
  • ALAB N/A
  • EPS Growth
  • BMRN 152.82
  • ALAB N/A
  • EPS
  • BMRN 2.71
  • ALAB 0.26
  • Revenue
  • BMRN $2,950,227,000.00
  • ALAB $490,474,000.00
  • Revenue This Year
  • BMRN $12.27
  • ALAB $72.55
  • Revenue Next Year
  • BMRN $9.86
  • ALAB $31.71
  • P/E Ratio
  • BMRN $22.11
  • ALAB $279.97
  • Revenue Growth
  • BMRN 19.36
  • ALAB 200.19
  • 52 Week Low
  • BMRN $52.93
  • ALAB $36.22
  • 52 Week High
  • BMRN $94.85
  • ALAB $147.39
  • Technical
  • Relative Strength Index (RSI)
  • BMRN 40.34
  • ALAB N/A
  • Support Level
  • BMRN $60.92
  • ALAB N/A
  • Resistance Level
  • BMRN $65.40
  • ALAB N/A
  • Average True Range (ATR)
  • BMRN 1.96
  • ALAB 0.00
  • MACD
  • BMRN 0.06
  • ALAB 0.00
  • Stochastic Oscillator
  • BMRN 21.52
  • ALAB 0.00

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.

About ALAB ASTERA LABS INC

Astera Labs Inc designs and delivers semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform integrates semiconductor technology, microcontrollers, sensors, and software to enhance performance, scalability, and data management. The company offers products such as integrated circuits (ICs), boards, and modules, catering to hyperscalers and system OEMs. The company's solutions focus on data, network, and memory management in AI-driven platforms.

Share on Social Networks: